|
CCDC112 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62614366416847E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73696645744803E-12 |
| Normal-vs-Stage2 |
4.02689992462513E-10 |
| Normal-vs-Stage3 |
6.29496454962464E-14 |
| Normal-vs-Stage4 |
3.10730330355113E-11 |
| Stage1-vs-Stage2 |
5.113600E-01 |
| Stage1-vs-Stage3 |
1.422560E-01 |
| Stage1-vs-Stage4 |
9.972200E-02 |
| Stage2-vs-Stage3 |
6.723200E-01 |
| Stage2-vs-Stage4 |
4.094600E-01 |
| Stage3-vs-Stage4 |
5.870200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16573417585641E-13 |
| Normal-vs-AfricanAmerican |
1.24879995233584E-09 |
| Normal-vs-Asian |
2.93040003374045E-09 |
| Caucasian-vs-AfricanAmerican |
1.827840E-01 |
| Caucasian-vs-Asian |
6.706600E-01 |
| AfricanAmerican-vs-Asian |
3.696400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16250367507587E-11 |
| Normal-vs-Female |
1.62703184258817E-12 |
| Male-vs-Female |
3.099600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.95069557465899E-11 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(61-80Yrs) |
3.62465613079621E-12 |
| Normal-vs-Age(81-100Yrs) |
1.259980E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.957000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.704600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.229400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.449600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.815760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.044600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.232600E-01 |
| Classical-VS-Follicular |
4.433700E-02 |
| Classical-VS-Other |
8.932400E-01 |
| Classical-VS-Normal |
4.46609416115962E-12 |
| Tall-VS-Follicular |
6.285600E-01 |
| Tall-VS-Other |
7.222600E-01 |
| Tall-VS-Normal |
2.37909999478703E-08 |
| Follicular-VS-Other |
5.998000E-01 |
| Follicular-VS-Normal |
1.73194791841524E-12 |
| Other-VS-Normal |
1.126100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18016707517654E-13 |
| Normal-vs-N1 |
6.79190037544686E-11 |
| N0-vs-N1 |
5.844600E-01 |
|
|
